SNCG and glaucoma: Previous studies have demonstrated the involvement of synucleins in the pathogenesis of ocular neurodegenerative diseases 12, 13, 61, such as glaucoma, characterized by progressive loss of RGCs and axon atrophy, leading to visual field loss 62.